COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases

Clinical trial NCT04806113 · COMPLETED

Trial details

NCT number: NCT04806113
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 Rheumatic Diseases Rheumatoid Arthritis SLE

Start date: 2021-03-11
Primary completion: 2021-06-13
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.